lansoprazole has been researched along with Insulin Resistance in 5 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Also, insulin resistance was calculated using the homeostatic model assessment of insulin resistance (HOMA-IR)." | 2.80 | The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. ( Dogan, Z; Ergul, B; Filik, L; Sarikaya, M, 2015) |
| "Global rates of obesity and type 2 diabetes mellitus (T2DM) are increasing globally concomitant with a rising prevalence of sleep deprivation and sleep disorders." | 2.72 | The links between sleep duration, obesity and type 2 diabetes mellitus. ( Antza, C; Kostopoulos, G; Mostafa, S; Nirantharakumar, K; Tahrani, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antza, C | 1 |
| Kostopoulos, G | 1 |
| Mostafa, S | 1 |
| Nirantharakumar, K | 1 |
| Tahrani, A | 1 |
| Gamil, NM | 1 |
| Abd El Fattah, MA | 1 |
| Ahmed, MAE | 1 |
| Maklad, YA | 1 |
| Gamal El Din, AA | 1 |
| Eid, NI | 1 |
| Dik, B | 1 |
| Coşkun, D | 1 |
| Bahçivan, E | 1 |
| Üney, K | 1 |
| Dogan, Z | 1 |
| Sarikaya, M | 1 |
| Ergul, B | 1 |
| Filik, L | 1 |
| Takebayashi, K | 1 |
| Sakurai, S | 1 |
| Suzuki, T | 1 |
| Hori, K | 1 |
| Terasawa, T | 1 |
| Naruse, R | 1 |
| Hara, K | 1 |
| Suetsugu, M | 1 |
| Tsuchiya, T | 1 |
| Aoki, H | 1 |
| Hamasaki, T | 1 |
| Shuutou, H | 1 |
| Inukai, T | 1 |
1 review available for lansoprazole and Insulin Resistance
| Article | Year |
|---|---|
The links between sleep duration, obesity and type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Lansoprazole; Life Style; Obesity; Risk Facto | 2021 |
2 trials available for lansoprazole and Insulin Resistance
| Article | Year |
|---|---|
The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Drug Therapy, Combination; | 2015 |
Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Co | 2014 |
2 other studies available for lansoprazole and Insulin Resistance
| Article | Year |
|---|---|
Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet-fed streptozotocin-treated diabetic rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimen | 2020 |
Potential antidiabetic activity of benzimidazole derivative albendazole and lansoprazole drugs in different doses in experimental type 2 diabetic rats
Topics: Albendazole; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glu | 2021 |